Session 4: Risk stratification and prevention in ductal in situ carcinoma
Chairs: Jens Huober (Germany), Jonas Bergh (Sweden)
- Risk stratification in patients with ductal carcinoma in situ (Fraser Symmans, USA)
- Estimating the magnitude of clinical benefit of local therapy in patients with DCIS (Shelley Hwang, USA)
- Estimating the magnitude of clinical benefit of systemic therapy in patients with DCIS (Andrea De Censi, Italy)
BCC2019 PARTICIPANT: PASSWORD in BCC e-mail from March 23.